32
original
SUPLEMENTO
Otoneurología 2014:
comprendiendomejor los trastornos vestibulares
Actual.Med.
2014; 99: (791). Supl. 32-60
Ménière’s syndromebymeans of transtympanic ventilation tubes.
ORL 1988; 50 (6): 377-81.
25. Plontke SK, Mynatt R, Gill RM, Borgmann S, Salt AN. Concentra-
tion gradient along the scala tympani after local application of
gentamicin to the round window membrane. Laryngoscope.
2007;117(7):1191-8.
26. ChoungYH, TauraA,PakK,Choi SJ,MasudaM,RyanAF.Generation
of highly-reactiveoxygen species is closely related tohair cell dam-
age in rat organ of Corti treated with gentamicin. Neuroscience.
2009161(1):214-26.
27. Lyford-Pike S, Vogelheim C, Chu E, Della Santina CC, Carey JP.
Gentamicin isprimarily localized in vestibular type I hair cells
after intratympanic administration. J Assoc Res Otolaryngol.
2007;8(4):497-508.
28. Salt AN, Plontke SK. Principles of local drug delivery to the inner
ear. Audiol Neurootol. 2009;14(6):350-60.
29. McCall AA, Swan EE, Borenstein JT, Sewell WF, Kujawa SG, McK-
ennaMJ. Drugdelivery for treatment of inner ear disease: current
stateof knowledge. EarHear. 2010;31(2):156-65.
30. Pullens B, van Benthem PP. Intratympanic gentamicin for Mé-
nière’s disease or syndrome. Cochrane Database Syst Rev. 2011
Mar 16;3
31. Stokroos R, Kingma H. Selective vestibular ablation by intratym-
panic gentamicin in patients with unilateral activeMénière’s dis-
ease: aprospective, double-blind, placebo-controlled, randomized
clinical trial. ActaOtolaryngol. 2004;124(2):172-5.
32. Postema RJ, Kingma CM, Wit HP, Albers FW, Van Der Laan BF. In-
tratympanic gentamicin therapy for control of vertigo inunilateral
Menire’s disease: a prospective, double-blind, randomized, place-
bo-controlled trial. ActaOtolaryngol. 2008;128(8):876-80.
33. López- Escamez JA, Vilchez JR, Soto-Varela A, Santos-Perez S,
Perez-Garrigues H, Aran I, Lopez-Nevot MA. DRB1*1101 allele
may be associatedwithbilateralMeniere´s disease. Otol Neurotol
2007; 28: 891-5.
34. Lopez-Escamez JA, Saenz-Lopez P, Acosta L, Moreno A, Gazquez I,
Perez-Garrigues H, Lopez-Nevot A, Lopez-Nevot MA. Association
of a functional polymorphism of PTPN22 encoding a lymphoid
protein phosphatase in bilateral Meniere`s disease. Laryngoscope
2010; 120: 103-7.
35. Doyle KJ, Bauch C, Battista R, Beatty C, Hughes GB,Mason J,Maw
J,Musiek FL. Intratympanic steroid treatment: a review. Otol Neu-
rotol. 2004;25(6):1034-9.
36. AllesMJ, derGaagMA, StokroosRJ. Intratympanic steroid therapy
for inner ear diseases, a review of the literature. Eur ArchOtorhi-
nolaryngol. 2006;263 (9):791-7.
37. HamidM, TruneD. Issues, indications, and controversies regarding
intratympanic steroidperfusion. CurrOpinOtolaryngol HeadNeck
Surg. 2008;16(5):434-40.
38. Sakata E, Ito Y, Itoh A. Clinical Experiences of Steroid Target-
ing Therapy to Inner Ear for Control of Tinnitus. Int Tinnitus J.
1997;3(2):117-121.
39. Garduño-AnayaMA, Couthino De Toledo H, Hinojosa-González R,
Pane-PianeseC, Ríos-Castañeda LC. Dexamethasone inner ear per-
fusion by intratympanic injection in unilateral Ménière’s disease:
a two-year prospective, placebo-controlled, double-blind, rand-
omized trial. Otolaryngol HeadNeck Surg. 2005;133(2):285-94.
40. Phillips JS,WesterbergB. Intratympanic steroids forMénière’s dis-
easeorsyndrome.CochraneDatabaseSystRev.2011;(7):CD008514.
41. Herraiz C, Plaza G, Aparicio JM, Gallego I, Marcos S, Ruiz C.
Transtympanic steroids for Ménière’s disease. Otol Neurotol.
2010;31(1):162-7.
42. Espinosa-Sánchez JM, Lopez-Escamez JA. Migraña vestibular: un
diagnósticoemergente.ActaOtorrinolaringolEsp.2013;64(6):387–
8.
43. NeffBA, Staab JP, EggersSD,CarlsonML, SchmittWR,VanAbel KM,
et al. Auditory and Vestibular Symptoms and Chronic Subjective
Dizziness inPatientsWithMénière“sDisease, VestibularMigraine,
and Ménière”s Disease With Concomitant Vestibular Migraine.
Otol Neurotol. 2012;33(7):1235–44.
44. Gao D, Ning N, Niu X, Hao G, Meng Z. Trimetazidine: a meta-
analysis of randomised controlled trials in heart failure. Heart.
2011;97(4):278-86.
45. Birks J, Grimley Evans J. Ginkgo biloba for cognitive impairment
anddementia. CochraneDatabase Syst Rev. 2009;(1):CD003120
46. Zeng X, Liu M, Yang Y, Li Y, Asplund K. Ginkgo biloba for acu-
te ischaemic stroke. Cochrane Database Syst Rev. 2005 Oct
19;(4):CD003691.
47. HiltonM, Stuart E. Ginkgo biloba for tinnitus. Cochrane Database
Syst Rev. 2004;(2):CD003852.
48. Nicolaï SP, Kruidenier LM, Bendermacher BL, PrinsMH, Teijink JA.
Ginkgo biloba for intermittent claudication. Cochrane Database
Syst Rev. 2009;(2):CD006888.
49. Espinosa-Sanchez JM, HeitzmannHernandez T, Lopez-Escamez JA.
Tratamiento farmacológico de los acúfenos: mucho ruido y pocas
nueces. RevNeurol 2014 (enprensa)
50. Thomsen J, Sass K, Odkvist L, Arlinger S. Local overpressure treat-
ment reduces vestibular symptoms inpatientswithMeniere’s dis-
ease: a clinical, randomized, multicenter, double-blind, placebo-
controlled study. Otol Neurotol. 2005;26(1):68-73.
51. Gates GA, Verrall A, Green JD Jr, Tucci DL, Telian SA.Meniett clini-
cal trial: long-term follow-up. Arch Otolaryngol Head Neck Surg.
2006;132 (12):1311-6.
52. Dornhoffer JL, King D. The effect of the Meniett device in pa-
tients with Ménière’s disease: long-term results. Otol Neurotol.
2008;29(6):868-74.
53. ShojakuH,WatanabeY,MinetaH,AokiM, TsubotaM,WatanabeK,
GotoF, ShigenoK. Long-termeffectsof theMeniettdevice in Japa-
nese patients withMeniere’s disease and delayed endolymphatic
hydrops reported by theMiddle Ear Pressure Treatment Research
Groupof Japan. ActaOtolaryngol. 2011;131(3):277-83.
54. Keinjung T. Low-level laser therapy. In: Møller AR, Langguth B,
DeRidder D, Kleinjung T, editors. Textbook of tinnitus. New York:
Springer; 2011.p.749-52.
55. SismanisA. Surgicalmanagementof commonperipheral vestibular
diseases. Curr OpinOtolaryngol HeadNeck Surg. 2010;18(5):431-
5.
56. Pullens B, Verschuur HP, van Benthem PP. Surgery for Ménière’s
disease. CochraneDatabase Syst Rev2013 Feb28;2:CD005395.
57. Vermeire K, Van deHeyning P. Binaural Hearing after cochlear im-
plantation in subjects with unilateral sensorineural deafness and
tinnitus. Audiol Neurotol. 2009; 14: 163-71.
58. VanHeyningP, VermeireK, DieblM,NoppP, Anderson I, DeRidder
D. Incapacitating unilateral tinnitus in single-sided deafness trea-
ted by cochlear implantation. Ann Otol Rhinol Laryngol 2008;
117(9): 645-652.
